Carregant...
Metformin use and risk of gastric adenocarcinoma in a Swedish population-based cohort study
BACKGROUND: Whether or not the use of metformin decreases the risk of gastric adenocarcinoma is unclear. METHODS: This was a population-based cohort study in 2005–2015. Associations between metformin use and gastric non-cardia and cardia adenocarcinomas were examined within two cohorts; a diabetes c...
Guardat en:
| Publicat a: | Br J Cancer |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group UK
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6889304/ https://ncbi.nlm.nih.gov/pubmed/31591459 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-019-0598-z |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|